The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
CD39 and CD73 in immunity and inflammation
Open accessAbstract
The enzymatic activities of CD39 and CD73 play strategic roles in calibrating the duration, magnitude, and chemical nature of purinergic signals delivered to immune cells through the conversion of ADP/ATP to AMP and AMP to adenosine, respectively. This drives a shift from an ATP-driven proinflammatory environment to an anti-inflammatory milieu induced by adenosine. The CD39/CD73 pathway changes dynamically with the pathophysiological context in which it is embedded. It is becoming increasingly appreciated that altering this catabolic machinery can change the course or dictate the outcome of several pathophysiological events, such as AIDS, autoimmune diseases, infections, atherosclerosis, ischemia-reperfusion injury, and cancer, suggesting these ecto-enzymes are novel therapeutic targets for managing a variety of disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Hart, M. L., Grenz, A., Gorzolla, I. C., Schittenhelm, J., Dalton, J. H., & Eltzschig, H. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903617 · Cited by 132
RetractedVignali, D. A. A., Collison, L. W., & Workman, C. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2343 · Cited by 3,463
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J.-F., Enjyoji, K., Linden, J., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,470
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Linden, J., & Müller, C. E. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003285 · Cited by 1,301
Borsellino, G., Kleinewietfeld, M., Di Mitri, D., Sternjak, A., Diamantini, A., Giometto, R., Höpner, S., Centonze, D., Bernardi, G., Dell'Acqua, M. L., et al. (2007) · Blood · doi:10.1182/blood-2006-12-064527 · Cited by 1,286
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
Haskó, G., Linden, J., Cronstein, B., & Pacher, P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2638 · Cited by 1,217
Self-citationYegutkin, G. G. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.024 · Cited by 1,154
Adenosine: an endogenous regulator of innate immunity
Haskó, G. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.11.003 · Cited by 899
Self-citationATP Release Guides Neutrophil Chemotaxis via P2Y2 and A3 Receptors
Chen, Y., Corriden, R., Inoue, Y., Yip, L., Hashiguchi, N., Zinkernagel, A., Nizet, V., Insel, P. A., & Junger, W. G. (2006) · Science · doi:10.1126/science.1132559 · Cited by 858
Immune cell regulation by autocrine purinergic signalling
Junger, W. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri2938 · Cited by 810
Synnestvedt, K., Furuta, G. T., Comerford, K. M., Louis, N. A., Karhausen, J., Eltzschig, H. K., Hansen, K. R., Thompson, L. F., & Colgan, S. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15337 · Cited by 679
Synnestvedt, K., Furuta, G. T., Comerford, K. M., Louis, N., Karhausen, J., Eltzschig, H. K., Hansen, K. R., Thompson, L. F., & Colgan, S. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215337 · Cited by 660
Fundamentals of Endothelial Function for the Clinical Cardiologist
Verma, S., & Anderson, T. J. (2002) · Circulation · doi:10.1161/hc0502.104540 · Cited by 602
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
Stagg, J., Divisekera, U., McLaughlin, N., Sharkey, J., Pommey, S., Denoyer, D., Dwyer, K. M., & Smyth, M. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908801107 · Cited by 572
Enjyoji, K., Sévigny, J., Lin, Y., Frenette, P. S., Christie, P. D., Esch, J. S. A., Imai, M., Edelberg, J. M., Rayburn, H., Lech, M., et al. (1999) · Nature Medicine · doi:10.1038/12447 · Cited by 565
Crucial Role for Ecto-5′-Nucleotidase (CD73) in Vascular Leakage during Hypoxia
Thompson, L. F., Eltzschig, H. K., Ibla, J. C., Van De Wiele, C. J., Resta, R., Morote-Garcia, J. C., & Colgan, S. P. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040915 · Cited by 543
Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
Clayton, A., Al-Taei, S., Webber, J., Mason, M. D., & Tabi, Z. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003884 · Cited by 540 · cited 1×
“Recent mechanistic studies have shown that in addition to cell-associated CD39 and CD73, CD39and CD73-expressing cancer exosomes can also raise adenosine levels within the tumor microenvironment, thereby inhibiting T cell responses through stimulating A2A and A2B receptors [150].”
Coordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium
Eltzschig, H. K., Ibla, J. C., Furuta, G. T., Leonard, M. O., Jacobson, K. A., Enjyoji, K., Robson, S. C., & Colgan, S. P. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030891 · Cited by 499 · cited 1×
“There is evidence that the expression and function of this enzyme are upregulated under hypoxic conditions [34,35], as well as by the presence of several pro-inflammatory mediators, such as transforming growth factor (TGF)β, interferons (IFNs), tumor necrosis factor (TNF)-α, interleukin (IL)-1β and prostaglandin E2 [3…”
CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis
Fletcher, J. M., Lonergan, R., Costelloe, L., Kinsella, K., Moran, B., O'Farrelly, C., Tubridy, N., & Mills, K. H. G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901881 · Cited by 476
NT5E Mutations and Arterial Calcifications
St. Hilaire, C., Ziegler, S. G., Markello, T. C., Brusco, A., Groden, C., Gill, F., Carlson-Donohoe, H., Lederman, R. J., Chen, M. Y., Yang, D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0912923 · Cited by 455
Cardioprotection by Ecto-5′-Nucleotidase (CD73) and A 2B Adenosine Receptors
Eckle, T., Krahn, T., Grenz, A., Köhler, D., Mittelbronn, M., Ledent, C., Jacobson, M. A., Osswald, H., Thompson, L. F., Unertl, K., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.669697 · Cited by 435
Extracellular ATP in the Immune System: More Than Just a “Danger Signal”
Trautmann, A. (2009) · Science Signaling · doi:10.1126/scisignal.256pe6 · Cited by 403
CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
Stagg, J., Divisekera, U., Duret, H., Sparwasser, T., Teng, M. W. L., Darcy, P. K., & Smyth, M. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4246 · Cited by 401
Ohta, A., Kini, R., Ohta, A., Subramanian, M., Madasu, M., & Sitkovsky, M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00190 · Cited by 398
Mandapathil, M., Hilldorfer, B., Szczepanski, M. J., Czystowska, M., Szajnik, M., Ren, J., Lang, S., Jackson, E. K., Gorelik, E., & Whiteside, T. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047423 · Cited by 390
Adenosine promotes alternative macrophage activation via A2A and A2B receptors
Csóka, B., Selmeczy, Z., Koscsó, B., Németh, Z. H., Pacher, P., Murray, P. J., Kepka‐Lenhart, D., Jr., S. M. M., Gause, W. C., Leibovich, S. J., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-190934 · Cited by 376
Self-citationEltzschig, H. K., Thompson, L. F., Karhausen, J., Cotta, R. J., Ibla, J. C., Robson, S. C., & Colgan, S. P. (2004) · Blood · doi:10.1182/blood-2004-06-2066 · Cited by 370
CD73: a potent suppressor of antitumor immune responses
Beavis, P. A., Stagg, J., Darcy, P. K., & Smyth, M. J. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.02.009 · Cited by 355
Chalmin, F., Mignot, G., Bruchard, M., Chevriaux, A., Végran, F., Hichami, A., Ladoire, S., Derangère, V., Vincent, J., Masson, D., et al. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.019 · Cited by 338
Mizumoto, N., Kumamoto, T., Robson, S. C., Sévigny, J., Matsue, H., Enjyoji, K., & Takashima, A. (2002) · Nature Medicine · doi:10.1038/nm0402-358 · Cited by 327 · cited 1×
“[23] reported that CD39 on either bone-marrow derived dendritic cells or Langerhans cells, a type of dendritic cell in the skin, is required for the optimal stimulation of hapten-reactive T cells.”
CD39 and control of cellular immune responses
Dwyer, K. M., Deaglio, S., Gao, W., Friedman, D., Strom, T. B., & Robson, S. C. (2007) · Purinergic Signalling · doi:10.1007/s11302-006-9050-y · Cited by 289
Friedman, D. J., Künzli, B. M., A-Rahim, Y. I., Sevigny, J., Berberat, P. O., Enjyoji, K., Csizmadia, E., Friess, H., & Robson, S. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902869106 · Cited by 284
Cell-surface enzymes in control of leukocyte trafficking
Salmi, M., & Jalkanen, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1705 · Cited by 281
Sun, X., Wu, Y., Gao, W., Enjyoji, K., Csizmadia, E., Müller, C. E., Murakami, T., & Robson, S. C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.007 · Cited by 279
Zhang, B., Wang, Z., Wu, L., Zhang, M., Li, W., Ding, J., Zhu, J., Wei, H., & Zhao, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057114 · Cited by 269
The ‘danger’ sensors that STOP the immune response: the A2 adenosine receptors?
Sitkovsky, M. V., & Ohta, A. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.04.004 · Cited by 265
The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization.
Maliszewski, C. R., Delespesse, G. J. T., Schoenborn, M. A., Armitage, R. J., Fanslow, W. C., Nakajima, T., Baker, E., Sutherland, G. R., Poindexter, K., Birks, C., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.8.3574 · Cited by 262
Regulation of Neutrophil Function by Adenosine
Barletta, K. E., Ley, K., & Mehrad, B. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.226845 · Cited by 260
Staphylococcus aureus synthesizes adenosine to escape host immune responses
Thammavongsa, V., Kern, J. W., Missiakas, D. M., & Schneewind, O. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090097 · Cited by 252
Ectonucleotidases as Regulators of Purinergic Signaling in Thrombosis, Inflammation, and Immunity
Deaglio, S., & Robson, S. C. (2011) · Advances in Pharmacology · doi:10.1016/b978-0-12-385526-8.00010-2 · Cited by 250
Schetinger, M. R. C., Morsch, V. M., Bonan, C. D., & Wyse, A. T. S. (2007) · BioFactors · doi:10.1002/biof.5520310205 · Cited by 250
Central role of Sp1-regulated CD39 in hypoxia/ischemia protection
Eltzschig, H. K., Köhler, D., Eckle, T., Kong, T., Robson, S. C., & Colgan, S. P. (2009) · Blood · doi:10.1182/blood-2008-06-165746 · Cited by 244
Koszalka, P., Özüyaman, B., Huo, Y., Zernecke, A., Flögel, U., Braun, N., Buchheiser, A., Decking, U. K. M., Smith, M. L., Sévigny, J., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000144796.82787.6f · Cited by 236
Lennon, P. F., Taylor, C. T., Stahl, G. L., & Colgan, S. P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1433 · Cited by 229
Köhler, D., Eckle, T., Faigle, M., Grenz, A., Mittelbronn, M., Laucher, S., Hart, M. L., Robson, S. C., Müller, C. E., & Eltzschig, H. K. (2007) · Circulation · doi:10.1161/circulationaha.107.690180 · Cited by 225
Regulation of Macrophage Function by Adenosine
Haskó, G., & Pacher, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.226852 · Cited by 223
Self-citationImmune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy
Chew, V., Toh, H. C., & Abastado, J.-P. (2012) · Journal of Oncology · doi:10.1155/2012/608406 · Cited by 218
Expression of CD39 by Human Peripheral Blood CD4+CD25+ T Cells Denotes a Regulatory Memory Phenotype
Dwyer, K. M., Hanidziar, D., Putheti, P., Hill, P. A., Pommey, S., McRae, J. L., Winterhalter, A., Doherty, G., Deaglio, S., Koulmanda, M., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03291.x · Cited by 216
The Reno-Vascular A2B Adenosine Receptor Protects the Kidney from Ischemia
Grenz, A., Osswald, H., Eckle, T., Yang, D., Zhang, H., Tran, Z. V., Klingel, K., Ravid, K., & Eltzschig, H. K. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050137 · Cited by 216
CD73-Deficient Mice Are Resistant to Carcinogenesis
Stagg, J., Beavis, P. A., Divisekera, U., Liu, M. C. P., Möller, A., Darcy, P. K., & Smyth, M. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0420 · Cited by 211
Mills, J. H., Thompson, L. F., Mueller, C., Waickman, A. T., Jalkanen, S., Niemela, J., Airas, L., & Bynoe, M. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711175105 · Cited by 209
Knapp, K., Zebisch, M., Pippel, J., El-Tayeb, A., Müller, C. E., & Sträter, N. (2012) · Structure · doi:10.1016/j.str.2012.10.001 · Cited by 207
ENTPD1/CD39 is a promising therapeutic target in oncology
Bastid, J., Cottalorda-Regairaz, A., Alberici, G., Bonnefoy, N., Eliaou, J.-F., & Bensussan, A. (2013) · Oncogene · doi:10.1038/onc.2012.269 · Cited by 202
Reutershan, J., Vollmer, I., Stark, S., Wagner, R., Ngamsri, K., & Eltzschig, H. K. (2009) · The FASEB Journal · doi:10.1096/fj.08-119701 · Cited by 200
Much Ado about Adenosine: Adenosine Synthesis and Function in Regulatory T Cell Biology
Ernst, P. B., Garrison, J. C., & Thompson, L. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000108 · Cited by 199
Zimmermann, H. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01293-6 · Cited by 198
Häusler, S. F. M., Montalbán del Barrio, I., Strohschein, J., Anoop Chandran, P., Engel, J. B., Hönig, A., Ossadnik, M., Horn, E., Fischer, B., Krockenberger, M., et al. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1040-4 · Cited by 193
Mandapathil, M., Szczepanski, M. J., Szajnik, M., Ren, J., Lenzner, D. E., Jackson, E. K., Gorelik, E., Lang, S., Johnson, J. T., & Whiteside, T. L. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1143 · Cited by 182
Ecto-5’-nucleotidase: Structure function relationships
Sträter, N. (2006) · Purinergic Signalling · doi:10.1007/s11302-006-9000-8 · Cited by 181
Antonioli, L., Colucci, R., La Motta, C., Tuccori, M., Awwad, O., Da Settimo, F., Blandizzi, C., & Fornai, M. (2012) · Current Drug Targets · doi:10.2174/138945012800564095 · Cited by 179
Self-citationHigh expression of CD73 as a poor prognostic biomarker in human colorectal cancer
Wu, X., He, X., Chen, Y., Yuan, R., Zeng, Y., Lian, L., Zou, Y., Lan, N., Wu, X., & Lan, P. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23056 · Cited by 178
CD39/Adenosine Pathway Is Involved in AIDS Progression
Nikolova, M., Carriere, M., Jenabian, M.-A., Limou, S., Younas, M., Kök, A., Huë, S., Seddiki, N., Hulin, A., Delaneau, O., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002110 · Cited by 177
Differential Macrophage Activation Alters the Expression Profile of NTPDase and Ecto-5′-Nucleotidase
Zanin, R. F., Braganhol, E., Bergamin, L. S., Campesato, L. F., Zanotto‐Filho, A., Moreira, J. C. F., Morrone, F. B., Sévigny, J., Schetinger, M. R. C., Wyse, Â. T. D. S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031205 · Cited by 175
Schulze zur Wiesch, J., Thomssen, A., Hartjen, P., Tóth, I., Lehmann, C., Meyer-Olson, D., Colberg, K., Frerk, S., Babikir, D., Schmiedel, S., et al. (2011) · Journal of Virology · doi:10.1128/jvi.01758-10 · Cited by 173
Genetics in Arterial Calcification: Pieces of a Puzzle and Cogs in a Wheel
Rutsch, F., Nitschke, Y., & Terkeltaub, R. (2011) · Circulation Research · doi:10.1161/circresaha.111.247965 · Cited by 172
Generation of anti‐inflammatory adenosine byleukocytes is regulated by TGF‐β
Regateiro, F. S., Howie, D., Nolan, K. F., Agorogiannis, E. I., Greaves, D. R., Cobbold, S. P., & Waldmann, H. (2011) · European Journal of Immunology · doi:10.1002/eji.201141512 · Cited by 166
Mandapathil, M., Lang, S., Gorelik, E., & Whiteside, T. L. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.05.004 · Cited by 163
Sperlágh, B., & Vizi, E. S. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795347564 · Cited by 161
Self-citationEpigenetics in atherosclerosis and inflammation
Wierda, R. J., Geutskens, S. B., Jukema, J. W., Quax, P. H. A., & van den Elsen, P. J. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01022.x · Cited by 160
Protective Role of Ecto-5′-Nucleotidase (CD73) in Renal Ischemia
Grenz, A., Zhang, H., Eckle, T. D. L. G., Mittelbronn, M. G. A., Wehrmann, M., Köhle, C., Kloor, D., Thompson, L. F., Oßwald, H., & Eltzschig, H. K. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006101141 · Cited by 158
Romio, M., Reinbeck, B., Bongardt, S., Hüls, S., Burghoff, S., & Schrader, J. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00385.2010 · Cited by 158
Contribution of E‐NTPDasel (CD39) to renal protection from ischemia‐reperfusion injury
Grenz, A., Zhang, H., Hermes, M., Eckle, T. D. L. G., Klingel, K., Huang, D. Y., Müller, C. E., Robson, S. C., Oßwald, H., & Eltzschig, H. K. (2007) · The FASEB Journal · doi:10.1096/fj.06-7947com · Cited by 157
Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease
Künzli, B. M., Berberat, P. O., Giese, T., Csizmadia, E., Kaczmarek, E., Baker, C., Halaceli, I., Büchler, M. W., Frieß, H., & Robson, S. C. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00259.2006 · Cited by 152
Autocrine Adenosine Signaling Promotes Regulatory T Cell–Mediated Renal Protection
Kinsey, G. R., Huang, L., Jaworska, K., Khutsishvili, K., Becker, D. A., Ye, H., Lobo, P. I., & Okusa, M. D. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010070 · Cited by 150
CD73/Ecto-5′-Nucleotidase Protects Against Vascular Inflammation and Neointima Formation
Zernecke, A., Bidzhekov, K., Özüyaman, B., Fraemohs, L., Liehn, E. A., Lüscher‐Firzlaff, J., Lüscher, B., Schrader, J., & Weber, C. (2006) · Circulation · doi:10.1161/circulationaha.105.595249 · Cited by 147
Feng, L., Sun, X., Csizmadia, E., Han, L., Shu, B., Murakami, T., Wang, X., Robson, S. C., & Wu, Y. (2011) · Neoplasia · doi:10.1593/neo.101332 · Cited by 145
Impact of Ectoenzymes on P2 and P1 Receptor Signaling
Kukulski, F., Lévesque, S. A., & Sévigny, J. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385526-8.00009-6 · Cited by 144
Serra, S., Horenstein, A. L., Vaisitti, T., Brusa, D., Rossi, D., Laurenti, L., D'Arena, G. F., Coscia, M., Tripodo, C., Inghirami, G., et al. (2011) · Blood · doi:10.1182/blood-2011-08-374728 · Cited by 142
Moncrieffe, H., Nistala, K., Kamhieh, Y., Evans, J., Eddaoudi, A., Eaton, S. D., & Wedderburn, L. R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0803474 · Cited by 142
Sun, H.-L., Xin Min, Z. H. O. U., Xue, Y., Wang, K., Shen, Y., Mao, J., Guo, H., & Miao, Z. (2012) · Europe PMC (PubMed Central) · doi:10.3748/wjg.v18.i25.3303 · Cited by 138
Alam, M. S., Kurtz, C. C., Rowlett, R. M., Reuter, B. K., Wiznerowicz, E. B., Das, S., Linden, J. M., Crowe, S. E., & Ernst, P. B. (2009) · The Journal of Infectious Diseases · doi:10.1086/596205 · Cited by 135
P2 receptors: new potential players in atherosclerosis
Virgilio, F. D., & Solini, A. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704524 · Cited by 132
Disordered Cellular Migration and Angiogenesis in cd39- Null Mice
Goepfert, C., Sundberg, C., Sévigny, J., Enjyoji, K., Hoshi, T., Csizmadia, E., & Robson, S. C. (2001) · Circulation · doi:10.1161/hc5001.100663 · Cited by 132
Corriden, R., Chen, Y., Inoue, Y., Beldi, G., Robson, S. C., Insel, P. A., & JUNGER, W. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800039200 · Cited by 131
Sperlágh, B., Haskó, G., Németh, Z., & Vizi, E. S. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(98)00025-4 · Cited by 130
Self-citationHart, M. L., Much, C. C., Gorzolla, I. C., Schittenhelm, J., Kloor, D., Stahl, G. L., & Eltzschig, H. K. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.064 · Cited by 125
Ring, S., Oliver, S. J., Cronstein, B. N., Enk, A., & Mahnke, K. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.03.022 · Cited by 124
Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer
Künzli, B. M., Bernlochner, M.-I., Rath, S., Käser, S. A., Csizmadia, E., Enjyoji, K., Cowan, P. J., d’Apice, A. J. F., Dwyer, K. M., Rosenberg, R., et al. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9228-9 · Cited by 123
SP1-Dependent Induction of CD39 Facilitates Hepatic Ischemic Preconditioning
Hart, M. L., Gorzolla, I. C., Schittenhelm, J., Robson, S. C., & Eltzschig, H. K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901851 · Cited by 122
Flögel, U., Burghoff, S., van Lent, P. L. E. M., Temme, S., Galbarz, L., Ding, Z., El‐Tayeb, A., Hüls, S., Bönner, F., Borg, N., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003717 · Cited by 122
Eltzschig, H. K., MacManus, C. F., & Colgan, S. P. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2008.01.006 · Cited by 121
Markello, T. C., Pak, L. K., Hilaire, C. S., Dorward, H. M., Ziegler, S. G., Chen, M. Y., Chaganti, K., Nussbaum, R. L., Boehm, M., & Gahl, W. A. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.01.018 · Cited by 120
NTPDase1 governs P2X7‐dependent functions in murine macrophages
Lévesque, S. A., Kukulski, F., Enjyoji, K., Robson, S. C., & Sévigny, J. (2010) · European Journal of Immunology · doi:10.1002/eji.200939741 · Cited by 119
Hart, M. L., Gorzolla, I. C., Schittenhelm, J., Dalton, J. H., & Eltzschig, H. K. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700997 · Cited by 116
Schuler, P. J., Schilling, B., Harasymczuk, M., Hoffmann, T. K., Johnson, J. T., Lang, S., & Whiteside, T. L. (2012) · European Journal of Immunology · doi:10.1002/eji.201142347 · Cited by 114
Nucleotide Metabolism and Cell-Cell Interactions
Eltzschig, H. K., Weissmüller, T., Mager, A., & Eckle, T. D. L. G. (2006) · Humana Press eBooks · doi:10.1385/1-59745-113-4:73 · Cited by 110
Bönner, F., Borg, N., Burghoff, S., & Schrader, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034730 · Cited by 109
Crikis, S., Lu, B., Murray‐Segal, L., Selan, C., Robson, S. C., 'Apice, A. J. F., Nandurkar, H. H., Cowan, P. J., & Dwyer, K. M. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03257.x · Cited by 108
CD73 promotes tumor growth and metastasis
Zhang, B. (2012) · OncoImmunology · doi:10.4161/onci.1.1.18068 · Cited by 106
Expression of ecto-5′-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma
Sądej, R., Spychała, J., & Składanowski, A. C. (2006) · Melanoma Research · doi:10.1097/01.cmr.0000215030.69823.11 · Cited by 106
Ecto-5′-Nucleotidase (CD73) Decreases Mortality and Organ Injury in Sepsis
Haskó, G., Csóka, B., Koscsó, B., Chandra, R., Pacher, P., Thompson, L. F., Deitch, E. A., Spolarics, Z., Virág, L., Gergely, P., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003379 · Cited by 106
Self-citationDeletion of Cd39/Entpd1 Results in Hepatic Insulin Resistance
Enjyoji, K., Kotani, K., Thukral, C., Blumel, B., Sun, X., Wu, Y., Imai, M., Friedman, D. J., Csizmadia, E., Bleibel, W., et al. (2008) · Diabetes · doi:10.2337/db07-1265 · Cited by 105
Disordered Purinergic Signaling Inhibits Pathological Angiogenesis in Cd39/Entpd1-Null Mice
Jackson, S. W., Hoshi, T., Wu, Y., Sun, X., Enjyoji, K., Cszimadia, E., Sundberg, C., & Robson, S. C. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070190 · Cited by 104
Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia‐reperfusion injury
Hart, M. L., Henn, M., Köhler, D., Kloor, D., Mittelbronn, M. G. A., Gorzolla, I. C., Stahl, G. L., & Eltzschig, H. K. (2008) · The FASEB Journal · doi:10.1096/fj.07-103911 · Cited by 104
Adenosine receptor activation ameliorates type 1 diabetes
Nemeth, Z. H., Bleich, D., Csóka, B., Pacher, P., Mabley, J. G., Himer, L., Vizi, E. S., Deitch, E. A., Szabó, C., Cronstein, B. N., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8213com · Cited by 103
Self-citationCD73-Generated Adenosine Restricts Lymphocyte Migration into Draining Lymph Nodes
Takedachi, M., Qu, D., Ebisuno, Y., Oohara, H., Joachims, M. L., McGee, S. T., Maeda, E., McEver, R. P., Tanaka, T. T., Miyasaka, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6288 · Cited by 93
CD39/NTPDase-1 activity and expression in normal leukocytes
Pulte, D. D., Broekman, M. J., Olson, K. E., Drosopoulos, J. H. F., Kizer, J. R., Islam, N., & Marcus, A. J. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2007.04.008 · Cited by 93
Differential ectonucleotidase expression in human bladder cancer cell lines
Stella, J., Bavaresco, L., Braganhol, E., Rockenbach, L., Farias, P. F., Wink, M. R., Azambuja, A. A., Barrios, C. H., Morrone, F. B., & Battastini, A. M. O. (2009) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.01.035 · Cited by 90
Hilchey, S. P., Kobie, J. J., Cochran, M. R., Secor‐Socha, S., Wang, J.-C. E., Hyrien, O., Burack, R., Mosmann, T. R., Quataert, S. A., & Bernstein, S. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900475 · Cited by 87
Ecto‐ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas
Dzhandzhugazyan, K. N., Kirkin, A. F., Straten, P. T., & Zeuthen, J. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00603-6 · Cited by 86
Mills, J. H., Alabanza, L. M., Mahamed, D., & Bynoe, M. S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-193 · Cited by 86
IFN‐β regulates CD73 and adenosine expression at the blood–brain barrier
Niemelä, J., Ifergan, I., Yegutkin, G. G., Jalkanen, S., Prat, A., & Airas, L. M. (2008) · European Journal of Immunology · doi:10.1002/eji.200838437 · Cited by 85
Sansom, F. M., Newton, H. J., Crikis, S., Cianciotto, N. P., Cowan, P. J., d’Apice, A. J. F., & Hartland, E. L. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00924.x · Cited by 83
Crystal Structure of a Soluble Form of Human CD73 with Ecto‐5′‐Nucleotidase Activity
Heuts, D. P. H. M., Weissenborn, M. J., Olkhov, R. V., Shaw, A. M., Gummadova, J., Levy, C., & Scrutton, N. S. (2012) · ChemBioChem · doi:10.1002/cbic.201200426 · Cited by 82
Schuler, P. J., Harasymczuk, M., Schilling, B., Lang, S., & Whiteside, T. L. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.04.004 · Cited by 82
CD73 Is Critical for the Resolution of Murine Colonic Inflammation
Bynoe, M. S., Waickman, A. T., Mahamed, D., Mueller, C., Mills, J. H., & Czopik, A. K. (2012) · BioMed Research International · doi:10.1155/2012/260983 · Cited by 76
Effects of ecto-5'-nucleotidase on human breast cancer cell growth in vitro and in vivo
Zhou, X., Zhi, X., Zhou, P., Chen, S., Zhao, F., Shao, Z., Ou, Z., & Yin, L. (2007) · Oncology Reports · doi:10.3892/or.17.6.1341 · Cited by 74
Tissue-Resident Ecto-5′ Nucleotidase (CD73) Regulates Leukocyte Trafficking in the Ischemic Brain
Petrovic‐Djergovic, D., Hyman, M. C., Ray, J. J., Bouïs, D., Visovatti, S., Hayasaki, T., & Pinsky, D. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1003671 · Cited by 73
Santos, R. F., Pôssa, M. A. S., Bastos, M. S. E., Guedes, P. M. D. M., de Almeida, M. R., Demarco, R. C., Verjovski‐Almeida, S., Bahia, M. T., & Fietto, J. L. R. (2009) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000387 · Cited by 72
Clinical Utility of Regadenoson for Assessing Fractional Flow Reserve
Nair, P. K., Marroquin, O. C., Mulukutla, S. R., Khandhar, S., Gulati, V. K., Schindler, J. T., & Lee, J. S. (2011) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2011.07.011 · Cited by 70
Hongli, Sun, Xin, Zhou, Yifeng, Xue, Ke, K., Wang, Yunfeng, Y., ShenI, et al. (2012) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 70
Different role of CD73 in leukocyte trafficking via blood and lymph vessels
Ålgars, A., Karikoski, M., Yegutkin, G. G., Stoitzner, P., Niemelä, J., Salmi, M., & Jalkanen, S. (2011) · Blood · doi:10.1182/blood-2010-11-321646 · Cited by 68
Yegutkin, G. G., Wieringa, B., Robson, S. C., & Jalkanen, S. (2012) · The FASEB Journal · doi:10.1096/fj.12-205658 · Cited by 68
Fan, J., Zhang, Y., Chuang-Smith, O. N., Frank, K. L., Guenther, B. D., Kern, M., Schlievert, P. M., & Herzberg, M. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038059 · Cited by 64
Regulation of Foam Cells by Adenosine
Reiss, A. B., & Cronstein, B. N. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.226878 · Cited by 64
NTPDase1 Controls IL-8 Production by Human Neutrophils
Kukulski, F., Bahrami, F., Yebdri, F. B., Lecka, J., Martín-Satué, M., Lévesque, S. A., & Sévigny, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002680 · Cited by 62
Peelen, E., Damoiseaux, J. G. M. C., Smolders, J., Knippenberg, S. A. M., Menheere, P. P. C. A., Tervaert, J. W. C., Hupperts, R., & Thewissen, M. M. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.09.013 · Cited by 61
CD73 mediates adhesion of B cells to follicular dendritic cells
Airas, L. M., & Jalkanen, S. (1996) · Blood · doi:10.1182/blood.v88.5.1755.1755 · Cited by 59
Testasicca, M. C. D. S., de Assis, E. A., Gomes, R. S., da Silva, E. D. A. M., Melo, M. N., Fietto, J. L. R., & Afonso, L. (2010) · Acta Tropica · doi:10.1016/j.actatropica.2010.04.007 · Cited by 58
Leal, D. B. R., Streher, C. A., Bertoncheli, C. D. M., Carli, L. F. D., Leal, C. A. M., da Silva, J. E. P., Morsch, V. M., & Schetinger, M. R. C. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.10.009 · Cited by 56
Perry, C., Hazan‐Halevy, I., Kay, S., Cipok, M., Grisaru, D., Deutsch, V. R., Polliack, A., Naparstek, E., & Herishanu, Y. (2012) · Annals of Hematology · doi:10.1007/s00277-012-1425-2 · Cited by 55
Zhi, X., Wang, Y., Yu, J., Yu, J., Zhang, L., Yin, L., & Zhou, P. (2012) · IUBMB Life · doi:10.1002/iub.1086 · Cited by 54
Potent effect of interleukin-1β to evoke ATP and adenosine release from rat hippocampal slices
Sperlágh, B., Baranyi, M., Haskó, G., & Vizi, E. S. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.004 · Cited by 54
Self-citationLinden, J. M. (2006) · Science · doi:10.1126/science.1137190 · Cited by 51
Inactivation of CD73 promotes atherogenesis in apolipoprotein E-deficient mice
Buchheiser, A., Ebner, A., Burghoff, S., Ding, Z., Romio, M., Viethen, C., Lindecke, A., Köhrer, K., Fischer, J. W., & Schrader, J. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr218 · Cited by 50
García-Hernández, M. H., Portales‐Cervantes, L., Cortez-Espinosa, N., Morales, J. M. V., Fritche‐Salazar, J. F., Rivera-López, E., Rodríguez-Rivera, J., Quezada‐Calvillo, R., & Portales‐Pérez, D. P. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.03.022 · Cited by 49
Pommey, S., Lü, B., McRae, J. L., Stagg, J., Hill, P., Salvaris, E. J., Robson, S. C., d’Apice, A. J. F., Cowan, P. J., & Dwyer, K. M. (2012) · Hepatology · doi:10.1002/hep.25985 · Cited by 47
CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia
Pulte, D. D., Olson, K. E., Broekman, M. J., Islam, N., Ballard, H. S., Furman, R. R., Olson, A. E., & Marcus, A. J. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-23 · Cited by 47
CLINICAL UTILITY OF REGADENOSON FOR ASSESSING FRACTIONAL FLOW RESERVE
Nair, P. K., Khandhar, S., Gulati, V. K., Schindler, J. T., Marroquin, O. C., Mulukutla, S. R., & Lee, J. S. (2011) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(11)61849-4 · Cited by 46
Failure of Immune Homeostasis - The Consequences of Under and Over Reactivity
Crimeen‐Irwin, B., Scalzo‐Inguanti, K., Gloster, S. E., Mottram, P. L., & Plebanski, M. (2005) · Current Drug Targets - Immune Endocrine & Metabolic Disorders · doi:10.2174/156800805774912980 · Cited by 44
Autoimmunity in CD73/Ecto-5′-Nucleotidase Deficient Mice Induces Renal Injury
Blume, C. A., Felix, A., Shushakova, N., Gueler, F., Falk, C. S., Haller, H. G., & Schrader, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037100 · Cited by 42
Heterogeneity in extracellular nucleotide hydrolysis among clinical isolates ofTrichomonas vaginalis
Tasca, T., Bonan, C. D., Carli, G. A. D., Sarkis, J. J. F., & Alderete, J. F. (2005) · Parasitology · doi:10.1017/s0031182005007377 · Cited by 40
Airas, L. M., Niemelä, J., Yegutkin, G. G., & Jalkanen, S. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1423.067 · Cited by 37
Behdad, A., Sun, X., Khalpey, Z. I., Enjyoji, K., Wink, M., Wu, Y., Usheva, A., & Robson, S. C. (2009) · Purinergic Signalling · doi:10.1007/s11302-009-9158-y · Cited by 34
Sun, X., Imai, M., D, M. N.-M. M., Guckelberger, O., Enjyoji, K., Wu, Y., Khalpey, Z. I., Berberat, P. O., Munasinghe, J., & Robson, S. C. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9239-6 · Cited by 34
Kas-Deelen, A. M., Bakker, W. W., Olinga, P., Visser, J., de Maar, E. F., van Son, W. J., THE, T. H., & Harmsen, M. C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02085-3 · Cited by 34
Thyroid hormone upregulates ecto-5′-nucleotidase/CD73 in C6 rat glioma cells
Wink, M., Tamajusuku, A. S. K., Braganhol, E., Casali, É. A., Barreto‐Chaves, M. L. M., Sarkis, J. J. F., & Battastini, A. M. O. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(03)00197-7 · Cited by 33
Chia, J. S., McRae, J. L., Thomas, H. E., Fynch, S., Elkerbout, L., Hill, P., Murray‐Segal, L., Robson, S. C., Chen, J., d’Apice, A. J. F., et al. (2013) · Diabetes · doi:10.2337/db12-0625 · Cited by 33
Buffon, A., Wink, M., Ribeiro, B. V., Casali, É. A., Libermann, T. A., Zerbini, L. F., Robson, S. C., & Sarkis, J. J. F. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.05.004 · Cited by 30
Mercier, N., Kiviniemi, T., Saraste, A., Miiluniemi, M., Silvola, J. M. U., Jalkanen, S., & Yegutkin, G. G. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.10.002 · Cited by 29
Nekooeian, A. A., & Tabrizchi, R. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00250-6 · Cited by 28
Immunotherapies in Infectious Diseases
Kak, V., Sundareshan, V., Modi, J. M., & Khardori, N. M. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.04.002 · Cited by 26
Allergen-induced airway hyperresponsiveness is absent in ecto-5′-nucleotidase (CD73)-deficient mice
Schreiber, R., Castrop, H., & Kunzelmann, K. (2008) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-008-0543-0 · Cited by 26
Deletion of CD73 promotes dyslipidemia and intramyocellular lipid accumulation in muscle of mice
Burghoff, S., Flögel, U., Bongardt, S., Burkart, V., Sell, H., Tucci, S., Ikels, K., Eberhard, D., Kern, M., Klöting, N., et al. (2013) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2012.755547 · Cited by 24
CD73 and Adhesion of B-Cells to Follicular Dendritic Cells
Airas, L. M. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809058380 · Cited by 24
Overexpression of CD39 in Mouse Airways Promotes Bacteria-Induced Inflammation
Théâtre, E., Frederix, K., Guilmain, W., Delierneux, C., Lecut, C., Bettendorff, L., Bours, V., & Oury, C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102600 · Cited by 24
Lack of ecto-5′-nucleotidase (CD73) promotes arteriogenesis
Böring, Y. C., Flögel, U., Jacoby, C., Heil, M., Schaper, W. K. A., & Schrader, J. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs286 · Cited by 20
Yegutkin, G. G., Hytönen, J., Samburski, S. S., Yrjänäinen, H., Jalkanen, S., & Viljanen, M. K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902760 · Cited by 19
Russo-Abrahão, T., Cosentino‐Gomes, D., Gomes, M. T., Alviano, D. S., Alviano, C. S., LOPES, A. H. C. S., & Meyer‐Fernandes, J. R. (2011) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2011.02216.x · Cited by 17
ATP and arterial calcification
Fish, R. S., Klootwijk, E. D., Tam, F. W. K., Kleta, R., Wheeler, D. C., Unwin, R. J., & Norman, J. T. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12055 · Cited by 17
CD73 protects kidney from ischemia‐reperfusion injury through reduction of free radicals
Jian, R., Sun, Y., Wang, Y., Yu, J., Zhong, L., & Zhou, P. (2011) · Apmis · doi:10.1111/j.1600-0463.2011.02827.x · Cited by 17
Inflammation Versus Adaptive Immunity in Cancer Pathogenesis
Yaqub, S., & Aandahl, E. M. (2009) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v15.i1-2.20 · Cited by 15
Kapojos, J. J., van den Berg, A., Borghuis, T., Banas, B., Huitema, S., Poelstra, K., & Bakker, W. W. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.08.008 · Cited by 11
Animal Models of Airway Diseases
Thompson, L. F., Picher, M., & Blackburn, M. R. (2011) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-1217-1_8 · Cited by 5
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Drug resistance and combating drug resistance in cancer
Wang, X., Zhang, H., & Chen, X. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.10 · Cited by 1,085
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
Duhen, T., Duhen, R., Montler, R., Moses, J., Moudgil, T., de Miranda, N. F., Goodall, C. P., Blair, T. C., Fox, B. A., McDermott, J. E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05072-0 · Cited by 938
The ectonucleotidases CD 39 and CD 73: Novel checkpoint inhibitor targets
Allard, B., Longhi, M. S., Robson, S. C., & Stagg, J. (2017) · Immunological Reviews · doi:10.1111/imr.12528 · Cited by 927
Consensus guidelines for the detection of immunogenic cell death
Kepp, O., Senovilla, L., Vitale, I., Vacchelli, E., Adjemian, S., Agostinis, P., Apetoh, L., Aranda, F., Barnaba, V., Bloy, N., et al. (2014) · OncoImmunology · doi:10.4161/21624011.2014.955691 · Cited by 832
Targeting immunosuppressive adenosine in cancer
Vijayan, D., Young, A., Teng, M. W. L., & Smyth, M. J. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.86 · Cited by 840
Metadata
- Authors
- Antonioli, L., Pacher, P., Vizi, E. S., & Haskó, G.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 19
- Issue
- 6
- Pages
- 355-367
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2086556660
- Cited by
- 1,263
- References
- 165
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.